These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 9011481

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
    Ferenci P, Stauber R, Propst A, Fiedler R, Müller C, Gschwantler M, Schütze K, Datz C, Judmaier G, Vogel W, Krejs GJ, Gangl A.
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
    Tong MJ, Reddy KR, Lee WM, Pockros PJ, Hoefs JC, Keeffe EB, Hollinger FB, Hathcote EJ, White H, Foust RT, Jensen DM, Krawitt EL, Fromm H, Black M, Blatt LM, Klein M, Lubina J.
    Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
    [Abstract] [Full Text] [Related]

  • 4. Two years versus six months of interferon therapy for chronic hepatitis C.
    Farrell GC.
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):93S-98S. PubMed ID: 9011483
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients.
    Pol S, Thiers V, Carnot F, Zins B, Roméo R, Berthelot P, Bréchot C.
    Nephrol Dial Transplant; 1996 Dec; 11 Suppl 4():58-61. PubMed ID: 8918758
    [Abstract] [Full Text] [Related]

  • 6. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC, Bacon BR, Goldin RD.
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [Abstract] [Full Text] [Related]

  • 7. Recombinant interferon-alfa therapy in children with chronic hepatitis C.
    Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, Nebbia G, Zancan L, De Moliner L, Bertolini A.
    Hepatology; 1995 Dec; 22(6):1623-7. PubMed ID: 7489965
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon.
    Almasio PL, Di Marco V, Bonura C, Fuschi P, Camma C, Lo Iacono O, Artini M, Natoli C, Di Stefano R, Levrero M, Craxi A.
    Dig Dis Sci; 1999 May; 44(5):1013-9. PubMed ID: 10235612
    [Abstract] [Full Text] [Related]

  • 10. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G, Borghesio E, Mesina P, Solinas A, Spezia C, Macor F, Gallo V, Chiandussi L, Donada C, Donadon V, Spirito F, Mangia A, Andriulli A, Verme G, Rizzetto M.
    J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM, Esforzado N, Martínez J, Roselló L, Veciana L, Modol J, Casellas J, Pons M, de Las Cuevas X, Piera J, Oliva JA, Costa J, Barrera JM, Bruguera M.
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [Abstract] [Full Text] [Related]

  • 12. Effects of interferon-alpha on serum hepatitis C virus in patients with chronic hepatitis C.
    Shibata M, Kumada T, Yamada M, Nakano S, Kudo T, Morishima T.
    Dig Dis Sci; 1993 Apr; 38(4):608-11. PubMed ID: 8384979
    [Abstract] [Full Text] [Related]

  • 13. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
    Mizokami M, Orito E, Gibo Y, Suzuki K, Ohba K, Ohno T, Lau JY.
    Liver; 1996 Feb; 16(1):23-7. PubMed ID: 8868074
    [Abstract] [Full Text] [Related]

  • 14. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM, Darthuy F, Rémiré J, Pellet C, Udin L, Stuyver L, Roudot-Thoraval F, Duvoux C, Douvin C, Mallat A.
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [Abstract] [Full Text] [Related]

  • 15. Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study.
    Flichman D, Colombatto P, Randone A, Baldi M, Bellati G, Negro F, Oliveri F, Colucci G, Verme G, Bonino F, Brunetto MR.
    Clin Diagn Virol; 1997 May; 8(1):63-70. PubMed ID: 9248659
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C.
    Kakizaki S, Takagi H, Yamada T, Ichikawa T, Abe T, Sohara N, Kosone T, Kaneko M, Takezawa J, Takayama H, Nagamine T, Mori M.
    J Viral Hepat; 1999 Jul; 6(4):315-9. PubMed ID: 10607246
    [Abstract] [Full Text] [Related]

  • 17. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
    Kakumu S, Yoshika K, Tanaka K, Higashi Y, Kurokawa S, Hirofuji H, Kusakabe A.
    J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
    [Abstract] [Full Text] [Related]

  • 18. Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases.
    Montalto G, Zignego AL, Ruggeri MI, Giannini C, Soresi M, Monti M, Carroccio A, Careccia G, Di Martino D, Giannelli F.
    Dig Dis Sci; 1997 Aug; 42(8):1703-7. PubMed ID: 9286237
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T.
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [Abstract] [Full Text] [Related]

  • 20. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
    Potthoff A, Wiegand J, Lüth JB, Wedemeyer H, Manns MP, Tillmann HL.
    Clin Nephrol; 2005 Mar; 63(3):232-5. PubMed ID: 15786827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.